Terms: = Lung cancer AND SF3B1, ENSG00000115524, 23451, O75533, SF3b155, SAP155, PRPF10, PRP10
27 results:
1. Synthesis and Conformational Analysis of FR901464-Based RNA Splicing Modulators and Their Synergism in Drug-Resistant cancers.
Beard JP; Bressin RK; Markaj PL; Schmitz JC; Koide K
J Med Chem; 2023 Nov; 66(21):14497-14512. PubMed ID: 37870431
[TBL] [Abstract] [Full Text] [Related]
2. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
[TBL] [Abstract] [Full Text] [Related]
3. Breast metastatic tumors in lung can be substituted by lung-derived malignant cells transformed by alternative splicing H19 lncRNA.
Xu JB; Cao J; Xia J; Zhu Y; He Y; Cao MG; Fang BM; Thiery JP; Zhou W
Breast Cancer Res; 2023 May; 25(1):59. PubMed ID: 37254190
[TBL] [Abstract] [Full Text] [Related]
4. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract] [Full Text] [Related]
5. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
Younes IE; Syler L; Hamed A
Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
[TBL] [Abstract] [Full Text] [Related]
6. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.
Weinstock JS; Gopakumar J; Burugula BB; Uddin MM; Jahn N; Belk JA; Bouzid H; Daniel B; Miao Z; Ly N; Mack TM; Luna SE; Prothro KP; Mitchell SR; Laurie CA; Broome JG; Taylor KD; Guo X; Sinner MF; von Falkenhausen AS; Kääb S; Shuldiner AR; O'Connell JR; Lewis JP; Boerwinkle E; Barnes KC; Chami N; Kenny EE; Loos RJF; Fornage M; Hou L; Lloyd-Jones DM; Redline S; Cade BE; Psaty BM; Bis JC; Brody JA; Silverman EK; Yun JH; Qiao D; Palmer ND; Freedman BI; Bowden DW; Cho MH; DeMeo DL; Vasan RS; Yanek LR; Becker LC; Kardia SLR; Peyser PA; He J; Rienstra M; Van der Harst P; Kaplan R; Heckbert SR; Smith NL; Wiggins KL; Arnett DK; Irvin MR; Tiwari H; Cutler MJ; Knight S; Muhlestein JB; Correa A; Raffield LM; Gao Y; de Andrade M; Rotter JI; Rich SS; Tracy RP; Konkle BA; Johnsen JM; Wheeler MM; Smith JG; Melander O; Nilsson PM; Custer BS; Duggirala R; Curran JE; Blangero J; McGarvey S; Williams LK; Xiao S; Yang M; Gu CC; Chen YI; Lee WJ; Marcus GM; Kane JP; Pullinger CR; Shoemaker MB; Darbar D; Roden DM; Albert C; Kooperberg C; Zhou Y; Manson JE; Desai P; Johnson AD; Mathias RA; ; Blackwell TW; Abecasis GR; Smith AV; Kang HM; Satpathy AT; Natarajan P; Kitzman JO; Whitsel EA; Reiner AP; Bick AG; Jaiswal S
Nature; 2023 Apr; 616(7958):755-763. PubMed ID: 37046083
[TBL] [Abstract] [Full Text] [Related]
7. Activation of
Biran A; Yin S; Kretzmer H; Ten Hacken E; Parvin S; Lucas F; Uduman M; Gutierrez C; Dangle N; Billington L; Regis FF; Rassenti LZ; Mohammad A; Hoffmann GB; Stevenson K; Zheng M; Witten E; Fernandes SM; Tausch E; Sun C; Stilgenbauer S; Brown JR; Kipps TJ; Aster JC; Gnirke A; Neuberg DS; Letai A; Wang L; Carrasco RD; Meissner A; Wu CJ
Cancer Res; 2021 Dec; 81(24):6117-6130. PubMed ID: 34686499
[TBL] [Abstract] [Full Text] [Related]
8. The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
Lafage-Pochitaloff M; Gerby B; Baccini V; Largeaud L; Fregona V; Prade N; Juvin PY; Jamrog L; Bories P; Hébrard S; Lagarde S; Mansat-De Mas V; Dovey OM; Yusa K; Vassiliou GS; Jansen JH; Tekath T; Rombaut D; Ameye G; Barin C; Bidet A; Boudjarane J; Collonge-Rame MA; Gervais C; Ittel A; Lefebvre C; Luquet I; Michaux L; Nadal N; Poirel HA; Radford-Weiss I; Ribourtout B; Richebourg S; Struski S; Terré C; Tigaud I; Penther D; Eclache V; Fontenay M; Broccardo C; Delabesse E
Blood Adv; 2022 Jan; 6(2):386-398. PubMed ID: 34638130
[TBL] [Abstract] [Full Text] [Related]
9. Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell lung cancer by Integrating SEER-Medicare Data.
Ye Q; Putila J; Raese R; Dong C; Qian Y; Dowlati A; Guo NL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299277
[TBL] [Abstract] [Full Text] [Related]
10. Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
Chang YS; Tu SJ; Chen YC; Liu TY; Lee YT; Yen JC; Fang HY; Chang JG
Respir Res; 2021 Jan; 22(1):3. PubMed ID: 33407425
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.
Oka M; Xu L; Suzuki T; Yoshikawa T; Sakamoto H; Uemura H; Yoshizawa AC; Suzuki Y; Nakatsura T; Ishihama Y; Suzuki A; Seki M
Genome Biol; 2021 Jan; 22(1):9. PubMed ID: 33397462
[TBL] [Abstract] [Full Text] [Related]
12. Genetic alterations of SUGP1 mimic mutant-sf3b1 splice pattern in lung adenocarcinoma and other cancers.
Alsafadi S; Dayot S; Tarin M; Houy A; Bellanger D; Cornella M; Wassef M; Waterfall JJ; Lehnert E; Roman-Roman S; Stern MH; Popova T
Oncogene; 2021 Jan; 40(1):85-96. PubMed ID: 33057152
[TBL] [Abstract] [Full Text] [Related]
13. Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell lung cancer Cells.
Blijlevens M; Komor MA; Sciarrillo R; Smit EF; Fijneman RJA; van Beusechem VW
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545483
[TBL] [Abstract] [Full Text] [Related]
14. Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for
Anbunathan H; Verstraten R; Singh AD; Harbour JW; Bowcock AM
Clin Cancer Res; 2019 Aug; 25(16):5156-5166. PubMed ID: 31227497
[TBL] [Abstract] [Full Text] [Related]
15. A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of sf3b1 Mutation and Atm Deletion.
Yin S; Gambe RG; Sun J; Martinez AZ; Cartun ZJ; Regis FFD; Wan Y; Fan J; Brooks AN; Herman SEM; Ten Hacken E; Taylor-Weiner A; Rassenti LZ; Ghia EM; Kipps TJ; Obeng EA; Cibulskis CL; Neuberg D; Campagna DR; Fleming MD; Ebert BL; Wiestner A; Leshchiner I; DeCaprio JA; Getz G; Reed R; Carrasco RD; Wu CJ; Wang L
Cancer Cell; 2019 Feb; 35(2):283-296.e5. PubMed ID: 30712845
[TBL] [Abstract] [Full Text] [Related]
16. Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.
Sciarrillo R; Wojtuszkiewicz A; El Hassouni B; Funel N; Gandellini P; Lagerweij T; Buonamici S; Blijlevens M; Zeeuw van der Laan EA; Zaffaroni N; Deraco M; Kusamura S; Würdinger T; Peters GJ; Molthoff CFM; Jansen G; Kaspers GJL; Cloos J; Giovannetti E
EBioMedicine; 2019 Jan; 39():215-225. PubMed ID: 30581150
[TBL] [Abstract] [Full Text] [Related]
17. Uncommon somatic mutations in metastatic NUT midline carcinoma.
Cavalieri S; Stathis A; Fabbri A; Sonzogni A; Perrone F; Tamborini E; Pelosi G; de Braud F; Platania M
Tumori; 2017 Nov; 103(Suppl. 1):e5-e8. PubMed ID: 28967088
[TBL] [Abstract] [Full Text] [Related]
18. Single-Nucleotide Polymorphism Leading to False Allelic Fraction by Droplet Digital PCR.
Christenson ES; Dalton WB; Chu D; Waters I; Cravero K; Zabransky DJ; DeZern AE; Park BH
Clin Chem; 2017 Aug; 63(8):1370-1376. PubMed ID: 28615231
[TBL] [Abstract] [Full Text] [Related]
19. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
[TBL] [Abstract] [Full Text] [Related]
20. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
[TBL] [Abstract] [Full Text] [Related]
[Next]
